A close above $18 would go a long way towards making breakout buyers feel better.
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
Let's check out the latest charts and indicators.
The stock has formed a bearish engulfing pattern.
With lockdowns ending and life as we knew it resuming to some extent, these three stocks should benefit.
State's dispensaries get OK to reopen recreational curbside service on May 25.
Bausch Health and Greenbrier Cos. have seen large chunks of their shares bought recently by people close to the companies.
The broad market may be soft for another week but if I find more stocks in a similar position as JNJ I won't see a reason to join the bear camp.
The big push for Alpha Pro Tech has been N95 masks, which we know are in huge demand, and here's a trade in the name right now.
The company has worked on two previous coronavirus vaccines as well as an Ebola vaccine.